更多...
收起
The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  由该基因编码的蛋白质是一种多功能的,核磷蛋白即在细胞周期进程,细胞凋亡和细胞转化的作用。它起到一种调节的特定靶基因转录的转录因子。突变,过度表达,重排和该基因的易位已与多种造血肿瘤,白血病和淋巴瘤,包括伯基特淋巴瘤有关。有证据表明,来自上游,在帧非-AUG(CUG)和下游AUG起始位点的结果在生产两种异构体具有不同的N-末端的替代翻译灌顶。非AUG启动蛋白的合成被抑制在伯基特淋巴瘤,表明该基因的正常功能的重要性。 [由RefSeq的,2008年7月提供]
MYC基因(以及对应的蛋白质)的细胞分布位置:
MYC基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Burkitt Lymphoma | 0.495996478 | 134 | 4 | BeFree_CLINVAR_CTD_human_LHGDN_MGD_ORPHANET |
| Liver carcinoma | 0.305750759 | 56 | 0 | BeFree_CTD_human_GAD_LHGDN_MGD_RGD |
| Colonic Neoplasms | 0.203538676 | 9 | 0 | BeFree_CTD_human_LHGDN_RGD |
| Liver Neoplasms, Experimental | 0.2 | 4 | 0 | CTD_human_RGD |
| Medulloblastoma | 0.139845051 | 46 | 0 | BeFree_CTD_human_LHGDN |
| Neoplasm Metastasis | 0.138392034 | 51 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Prostatic Neoplasms | 0.137974753 | 13 | 0 | BeFree_CTD_human_LHGDN |
| Leukemia, Myelocytic, Acute | 0.13549205 | 38 | 0 | BeFree_CTD_human_LHGDN |
| Neuroblastoma | 0.129771907 | 37 | 0 | BeFree_CTD_human |
| Liver neoplasms | 0.128977445 | 17 | 0 | BeFree_CTD_human_LHGDN |
| Bladder Neoplasm | 0.125720142 | 4 | 0 | BeFree_CTD_human_LHGDN |
| Pancreatic Neoplasm | 0.125091382 | 2 | 1 | CTD_human_GAD_LHGDN |
| Non-Small Cell Lung Carcinoma | 0.12434307 | 16 | 0 | BeFree_CTD_human |
| Glioblastoma | 0.123810118 | 6 | 0 | BeFree_CTD_human_LHGDN |
| ovarian neoplasm | 0.123810118 | 6 | 0 | BeFree_CTD_human_LHGDN |
| Hemangiosarcoma | 0.123528744 | 14 | 0 | BeFree_CTD_human |
| Lung Neoplasms | 0.121628651 | 7 | 0 | BeFree_CTD_human |
| Osteosarcoma | 0.121628651 | 7 | 0 | BeFree_CTD_human |
| Stomach Neoplasms | 0.121357209 | 7 | 0 | BeFree_CTD_human |
| Neuroectodermal Tumors | 0.121357209 | 6 | 0 | BeFree_CTD_human |
| Mammary Neoplasms | 0.121116832 | 36 | 0 | BeFree_LHGDN_RGD |
| Lymphoma, Small Noncleaved-Cell | 0.120542884 | 2 | 0 | BeFree_ORPHANET |
| MYELODYSPLASTIC SYNDROME | 0.120271442 | 2 | 0 | BeFree_CTD_human |
| Merkel cell carcinoma | 0.12 | 1 | 0 | CTD_human |
| Hypertrophic Cardiomyopathy | 0.12 | 1 | 0 | CTD_human |
| Neoplastic Cell Transformation | 0.12 | 1 | 0 | CTD_human |
| Cleft Lip | 0.12 | 1 | 0 | CTD_human |
| Cleft Palate | 0.12 | 1 | 0 | CTD_human |
| Fatty Liver | 0.12 | 1 | 0 | CTD_human |
| Polycystic Kidney, Autosomal Dominant | 0.12 | 1 | 0 | CTD_human |
| Left Ventricular Hypertrophy | 0.12 | 1 | 0 | CTD_human |
| Disease Progression | 0.12 | 1 | 0 | CTD_human |
| Chromosome Breakage | 0.12 | 1 | 0 | CTD_human |
| Malignant neoplasm of breast | 0.112888074 | 98 | 0 | BeFree_GAD_MGD |
| Renal Cell Carcinoma | 0.091430353 | 16 | 0 | BeFree_LHGDN_RGD |
| Esophageal Neoplasms | 0.083810118 | 5 | 0 | BeFree_LHGDN_RGD |
| Pancreatic carcinoma | 0.081628651 | 6 | 0 | BeFree_MGD |
| Polycystic Kidney Diseases | 0.080271442 | 2 | 0 | BeFree_RGD |
| Obesity | 0.080271442 | 2 | 0 | BeFree_RGD |
| Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
| Cardiomegaly | 0.08 | 1 | 0 | RGD |
| Pulmonary Hypertension | 0.08 | 1 | 0 | RGD |
| Fibroid Tumor | 0.08 | 1 | 0 | RGD |
| Osteoporosis | 0.08 | 1 | 0 | RGD |
| Prolactinoma | 0.08 | 1 | 0 | RGD |
| Shock, Hemorrhagic | 0.08 | 1 | 0 | RGD |
| Coronary Restenosis | 0.08 | 1 | 0 | RGD |
| Prostatic Hyperplasia | 0.08 | 1 | 0 | RGD |
| Lymphoma | 0.071267117 | 217 | 0 | BeFree_GAD_LHGDN |
| B-Cell Lymphomas | 0.04993888 | 113 | 0 | BeFree_GAD_LHGDN |
| Carcinogenesis | 0.034473118 | 127 | 0 | BeFree |
| Diffuse Large B-Cell Lymphoma | 0.029902213 | 85 | 0 | BeFree_GAD |
| Breast Carcinoma | 0.025786978 | 95 | 0 | BeFree |
| Malignant neoplasm of prostate | 0.019587422 | 47 | 3 | BeFree_GAD |
| Multiple Myeloma | 0.018749352 | 50 | 0 | BeFree_LHGDN |
| Adenocarcinoma | 0.018236263 | 22 | 1 | BeFree_LHGDN |
| Malignant neoplasm of lung | 0.014234529 | 37 | 0 | BeFree_GAD |
| melanoma | 0.01387333 | 23 | 0 | BeFree_LHGDN |
| Prostate carcinoma | 0.012486326 | 46 | 3 | BeFree |
| leukemia | 0.011943442 | 44 | 0 | BeFree |
| Colorectal Carcinoma | 0.011596056 | 35 | 4 | BeFree_GAD |
| Squamous cell carcinoma | 0.011530042 | 17 | 0 | BeFree_GAD_LHGDN |
| Colorectal Cancer | 0.011324614 | 34 | 4 | BeFree_GAD |
| Tumor Progression | 0.011129117 | 41 | 0 | BeFree |
| Small cell carcinoma of lung | 0.010857675 | 40 | 0 | BeFree |
| Leukemogenesis | 0.010043349 | 37 | 0 | BeFree |
| Colorectal Neoplasms | 0.00953026 | 8 | 0 | BeFree_LHGDN |
| Malignant neoplasm of stomach | 0.008881637 | 24 | 0 | BeFree_GAD |
| Carcinoma of lung | 0.00868614 | 32 | 0 | BeFree |
| Central neuroblastoma | 0.008414698 | 31 | 0 | BeFree |
| Lymphoma, Non-Hodgkin | 0.007991366 | 13 | 0 | BeFree_GAD |
| Stomach Carcinoma | 0.007871814 | 29 | 0 | BeFree |
| Malignant neoplasm of urinary bladder | 0.007719925 | 13 | 6 | BeFree_GAD |
| Colon Carcinoma | 0.007600372 | 28 | 0 | BeFree |
| Lymphoma, Follicular | 0.007524428 | 20 | 1 | BeFree_GAD |
| Mouth Neoplasms | 0.007458414 | 3 | 0 | GAD_LHGDN |
| Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.006795978 | 16 | 0 | BeFree_LHGDN |
| Anaplasia | 0.006263026 | 4 | 0 | BeFree_LHGDN |
| Chronic Lymphocytic Leukemia | 0.005971721 | 22 | 0 | BeFree |
| Anoxia | 0.0054487 | 2 | 0 | LHGDN |
| Barrett Esophagus | 0.0054487 | 2 | 0 | LHGDN |
| Congenital chromosomal disease | 0.005157396 | 19 | 0 | BeFree |
| Glioma | 0.004895885 | 9 | 0 | BeFree_LHGDN |
| Myeloid Leukemia, Chronic | 0.004885954 | 18 | 0 | BeFree |
| Malignant neoplasm of ovary | 0.004810009 | 10 | 0 | BeFree_GAD |
| Chromosomal translocation | 0.004734064 | 2 | 0 | GAD |
| Retinoblastoma | 0.004624443 | 8 | 0 | BeFree_LHGDN |
| Malignant tumor of colon | 0.004614512 | 17 | 0 | BeFree |
| Acute lymphocytic leukemia | 0.004614512 | 17 | 0 | BeFree |
| Ovarian Carcinoma | 0.00434307 | 16 | 0 | BeFree |
| Plasmacytoma | 0.00434307 | 16 | 0 | BeFree |
| Primary Effusion Lymphoma | 0.00408156 | 6 | 0 | BeFree_LHGDN |
| Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.004071628 | 15 | 0 | BeFree |
| Precursor B-cell lymphoblastic leukemia | 0.003800186 | 14 | 0 | BeFree |
| Carcinoma, Transitional Cell | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Hepatitis B | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| T-Cell Lymphoma | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Immunoblastic Large-Cell Lymphoma | 0.003528744 | 13 | 0 | BeFree |
| Epstein-Barr Virus Infections | 0.003528744 | 13 | 0 | BeFree |
| Plasmablastic lymphoma | 0.003528744 | 13 | 0 | BeFree |
| Rheumatoid Arthritis | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| Astrocytoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
| Papilloma | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| Meningioma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Sarcoma, Clear Cell | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Cholangiocarcinoma | 0.002995792 | 2 | 1 | BeFree_LHGDN |
| Secondary malignant neoplasm of lymph node | 0.002985861 | 11 | 0 | BeFree |
| Carcinoma of bladder | 0.002985861 | 11 | 6 | BeFree |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.002985861 | 11 | 0 | BeFree |
| Uterine Cervical Neoplasm | 0.00272435 | 1 | 0 | LHGDN |
| Cessation of life | 0.00272435 | 1 | 0 | LHGDN |
| Endometrial Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Neoplasms, Germ Cell and Embryonal | 0.00272435 | 1 | 0 | LHGDN |
| Varicose Ulcer | 0.00272435 | 1 | 0 | LHGDN |
| Werner Syndrome | 0.00272435 | 1 | 0 | LHGDN |
| Fibroadenoma | 0.00272435 | 1 | 0 | LHGDN |
| Nijmegen Breakage Syndrome | 0.00272435 | 1 | 0 | LHGDN |
| Infection | 0.00272435 | 1 | 0 | LHGDN |
| Acute Promyelocytic Leukemia | 0.002714419 | 10 | 0 | BeFree |
| Cervix carcinoma | 0.002714419 | 10 | 0 | BeFree |
| Thyroid Diseases | 0.002638474 | 1 | 0 | BeFree_GAD |
| Trisomy | 0.002442977 | 9 | 0 | BeFree |
| Adenocarcinoma of lung (disorder) | 0.002442977 | 9 | 0 | BeFree |
| Alzheimer's Disease | 0.002367032 | 1 | 0 | GAD |
| Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
| Thyroid Neoplasm | 0.002367032 | 1 | 0 | GAD |
| Acute leukemia | 0.002171535 | 8 | 0 | BeFree |
| Hematologic Neoplasms | 0.002171535 | 8 | 0 | BeFree |
| Sarcoma | 0.002171535 | 8 | 0 | BeFree |
| Hepatocarcinogenesis | 0.002171535 | 8 | 0 | BeFree |
| Nasopharyngeal carcinoma | 0.002171535 | 8 | 0 | BeFree |
| Adenomatous Polyposis Coli | 0.001900093 | 7 | 0 | BeFree |
| Esophageal carcinoma | 0.001900093 | 7 | 0 | BeFree |
| Mucosa-Associated Lymphoid Tissue Lymphoma | 0.001900093 | 7 | 0 | BeFree |
| Medulloblastoma, Childhood | 0.001900093 | 7 | 0 | BeFree |
| Gastric Adenocarcinoma | 0.001900093 | 7 | 0 | BeFree |
| Solid tumour | 0.001900093 | 7 | 0 | BeFree |
| Epithelial ovarian cancer | 0.001900093 | 7 | 0 | BeFree |
| Leukemia, T-Cell | 0.001628651 | 6 | 0 | BeFree |
| Isochromosomes | 0.001628651 | 6 | 0 | BeFree |
| Malignant neoplasm of pancreas | 0.001628651 | 6 | 0 | BeFree |
| Hematopoietic Neoplasms | 0.001628651 | 6 | 0 | BeFree |
| Chromosome 8, trisomy | 0.001628651 | 6 | 0 | BeFree |
| Malignant neoplasm of esophagus | 0.001628651 | 6 | 0 | BeFree |
| Osteosarcoma of bone | 0.001628651 | 6 | 0 | BeFree |
| Squamous cell carcinoma of the head and neck | 0.001628651 | 6 | 0 | BeFree |
| Promyelocytic leukemia | 0.001628651 | 6 | 0 | BeFree |
| Malignant tumor of cervix | 0.001357209 | 5 | 0 | BeFree |
| Lymphoid leukemia | 0.001357209 | 5 | 0 | BeFree |
| Myeloid Leukemia | 0.001357209 | 5 | 0 | BeFree |
| Pheochromocytoma | 0.001357209 | 5 | 0 | BeFree |
| High Grade Lymphoma (neoplasm) | 0.001357209 | 5 | 0 | BeFree |
| Neuroectodermal Tumor, Primitive | 0.001357209 | 5 | 0 | BeFree |
| Squamous cell carcinoma of esophagus | 0.001357209 | 5 | 0 | BeFree |
| Adenocarcinoma Of Esophagus | 0.001357209 | 5 | 0 | BeFree |
| Tumor Initiation | 0.001357209 | 5 | 0 | BeFree |
| Renal carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Vascular lesions | 0.001357209 | 5 | 0 | BeFree |
| Leukemia, B-Cell | 0.001357209 | 5 | 0 | BeFree |
| Adenoma | 0.001085767 | 4 | 0 | BeFree |
| Brain Neoplasms | 0.001085767 | 4 | 0 | BeFree |
| Diabetes | 0.001085767 | 4 | 0 | BeFree |
| Diabetes Mellitus | 0.001085767 | 4 | 0 | BeFree |
| HIV Infections | 0.001085767 | 4 | 0 | BeFree |
| Immunologic Deficiency Syndromes | 0.001085767 | 4 | 0 | BeFree |
| leiomyosarcoma | 0.001085767 | 4 | 0 | BeFree |
| Monosomy | 0.001085767 | 4 | 0 | BeFree |
| Rhabdomyosarcoma | 0.001085767 | 4 | 0 | BeFree |
| Ki-1+ Anaplastic Large Cell Lymphoma | 0.001085767 | 4 | 0 | BeFree |
| Multiple malignancy | 0.001085767 | 4 | 0 | BeFree |
| Secondary malignant neoplasm of liver | 0.001085767 | 4 | 0 | BeFree |
| Thyroid carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Aggressive Non-Hodgkin Lymphoma | 0.001085767 | 4 | 0 | BeFree |
| Mammary Tumorigenesis | 0.001085767 | 4 | 0 | BeFree |
| Non-Neoplastic Disorder | 0.001085767 | 4 | 0 | BeFree |
| Triple Negative Breast Neoplasms | 0.001085767 | 4 | 0 | BeFree |
| Blast Phase | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of thyroid | 0.000814326 | 3 | 0 | BeFree |
| Cholesteatoma | 0.000814326 | 3 | 0 | BeFree |
| Hodgkin Disease | 0.000814326 | 3 | 0 | BeFree |
| Leukemia, Plasma Cell | 0.000814326 | 3 | 0 | BeFree |
| Prolymphocytic Leukemia | 0.000814326 | 3 | 0 | BeFree |
| Adult T-Cell Lymphoma/Leukemia | 0.000814326 | 3 | 0 | BeFree |
| Monoclonal Gammopathy of Undetermined Significance | 0.000814326 | 3 | 0 | BeFree |
| Embryonal Neoplasm | 0.000814326 | 3 | 0 | BeFree |
| Melanocytic nevus | 0.000814326 | 3 | 0 | BeFree |
| Lymphoma, Large-Cell, Follicular | 0.000814326 | 3 | 0 | BeFree |
| Precursor cell lymphoblastic lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Lymphoma, AIDS-Related | 0.000814326 | 3 | 0 | BeFree |
| Liver and Intrahepatic Biliary Tract Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Extraosseous Ewings sarcoma-primitive neuroepithelial tumor | 0.000814326 | 3 | 0 | BeFree |
| Adenocarcinoma of colon | 0.000814326 | 3 | 0 | BeFree |
| African Burkitt's lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of liver | 0.000814326 | 3 | 0 | BeFree |
| Gastric lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000814326 | 3 | 0 | BeFree |
| Leukemia, Prolymphocytic, B-Cell | 0.000814326 | 3 | 0 | BeFree |
| Lymphoid neoplasm | 0.000814326 | 3 | 0 | BeFree |
| Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of kidney | 0.000814326 | 3 | 0 | BeFree |
| Invasive breast carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Mediastinal (Thymic) Large B-Cell Lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Invasive Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Radiation-Related Angiosarcoma | 0.000814326 | 3 | 0 | BeFree |
| Cardiomyopathy, Familial Idiopathic | 0.000814326 | 3 | 0 | BeFree |
| Xenograft Model | 0.000814326 | 3 | 1 | BeFree |
| Urothelial Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| T-Cell Prolymphocytic Leukemia | 0.000814326 | 3 | 0 | BeFree |
| Arteriosclerosis | 0.000542884 | 2 | 0 | BeFree |
| Ataxia Telangiectasia | 0.000542884 | 2 | 0 | BeFree |
| Atherosclerosis | 0.000542884 | 2 | 0 | BeFree |
| Carcinoid Tumor | 0.000542884 | 2 | 0 | BeFree |
| Noninfiltrating Intraductal Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Chondrosarcoma | 0.000542884 | 2 | 0 | BeFree |
| Choriocarcinoma | 0.000542884 | 2 | 0 | BeFree |
| Hepatitis | 0.000542884 | 2 | 0 | BeFree |
| Hepatitis A | 0.000542884 | 2 | 0 | BeFree |
| Hepatitis, Chronic | 0.000542884 | 2 | 0 | BeFree |
| Leukemia, Lymphocytic, Acute, L1 | 0.000542884 | 2 | 0 | BeFree |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Leukemia, T-Cell, Chronic | 0.000542884 | 2 | 0 | BeFree |
| liposarcoma | 0.000542884 | 2 | 0 | BeFree |
| Liver Cirrhosis | 0.000542884 | 2 | 0 | BeFree |
| Mycosis Fungoides | 0.000542884 | 2 | 0 | BeFree |
| Precancerous Conditions | 0.000542884 | 2 | 0 | BeFree |
| Preleukemia | 0.000542884 | 2 | 0 | BeFree |
| Retroviridae Infections | 0.000542884 | 2 | 0 | BeFree |
| Kaposi Sarcoma | 0.000542884 | 2 | 0 | BeFree |
| Systemic Scleroderma | 0.000542884 | 2 | 0 | BeFree |
| Thrombocythemia, Essential | 0.000542884 | 2 | 0 | BeFree |
| Thymoma | 0.000542884 | 2 | 0 | BeFree |
| Benign Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of brain | 0.000542884 | 2 | 0 | BeFree |
| Secondary malignant neoplasm of lung | 0.000542884 | 2 | 0 | BeFree |
| Adenocarcinoma, Tubular | 0.000542884 | 2 | 0 | BeFree |
| Medullomyoblastoma | 0.000542884 | 2 | 0 | BeFree |
| Cervical Intraepithelial Neoplasia | 0.000542884 | 2 | 0 | BeFree |
| Inflammatory Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Metastatic melanoma | 0.000542884 | 2 | 0 | BeFree |
| Conventional (Clear Cell) Renal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Vascular Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Prostatic Intraepithelial Neoplasias | 0.000542884 | 2 | 0 | BeFree |
| Nodular melanoma | 0.000542884 | 2 | 0 | BeFree |
| Malignant lymphoma - lymphoplasmacytic | 0.000542884 | 2 | 0 | BeFree |
| Giant cell carcinoma of lung | 0.000542884 | 2 | 0 | BeFree |
| Cervical intraepithelial neoplasia grade 1 | 0.000542884 | 2 | 0 | BeFree |
| Early gastric cancer | 0.000542884 | 2 | 0 | BeFree |
| Squamous cell carcinoma of tongue | 0.000542884 | 2 | 0 | BeFree |
| Richter's syndrome | 0.000542884 | 2 | 0 | BeFree |
| High grade B-cell lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Endometrial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Recurrent tumor | 0.000542884 | 2 | 0 | BeFree |
| Squamous cell carcinoma of skin | 0.000542884 | 2 | 0 | BeFree |
| Squamous cell carcinoma of mouth | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma of larynx | 0.000542884 | 2 | 0 | BeFree |
| invasive cancer | 0.000542884 | 2 | 0 | BeFree |
| extranodal lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Angiosarcoma non-metastatic | 0.000542884 | 2 | 0 | BeFree |
| Metastatic Prostate Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| precancerous lesions | 0.000542884 | 2 | 0 | BeFree |
| Invasive Ductal Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Monoclonal Gammapathies | 0.000542884 | 2 | 0 | BeFree |
| High-Grade Prostatic Intraepithelial Neoplasia | 0.000542884 | 2 | 0 | BeFree |
| Ductal Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Classical Burkitt Lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Pancreatic Ductal Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
| Sporadic Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Malignant Conversion | 0.000542884 | 2 | 0 | BeFree |
| Tumor Angiogenesis | 0.000542884 | 2 | 0 | BeFree |
| Benign Prostatic Hyperplasia | 0.000542884 | 2 | 0 | BeFree |
| Enchondroma | 0.000542884 | 2 | 0 | BeFree |
| Prostate cancer, familial | 0.000542884 | 2 | 0 | BeFree |
| aggressive cancer | 0.000542884 | 2 | 0 | BeFree |
| Congenital Abnormality | 0.000271442 | 1 | 0 | BeFree |
| Acquired Immunodeficiency Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Acromegaly | 0.000271442 | 1 | 0 | BeFree |
| Adrenal Gland Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Breast Diseases | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of endometrium | 0.000271442 | 1 | 0 | BeFree |
| Female Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mucinous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Coronary Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Coronary heart disease | 0.000271442 | 1 | 1 | BeFree |
| Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis D Infection | 0.000271442 | 1 | 0 | BeFree |
| Scleroderma | 0.000271442 | 1 | 0 | BeFree |
| Diabetes Mellitus, Insulin-Dependent | 0.000271442 | 1 | 0 | BeFree |
| Epithelial cyst | 0.000271442 | 1 | 0 | BeFree |
| Epilepsy, Temporal Lobe | 0.000271442 | 1 | 0 | BeFree |
| Failure to Thrive | 0.000271442 | 1 | 0 | BeFree |
| Graves Disease | 0.000271442 | 1 | 0 | BeFree |
| Heart Diseases | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis, Alcoholic | 0.000271442 | 1 | 0 | BeFree |
| Intestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Actinic keratosis | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, Lymphocytic, Acute, L2 | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, Myeloid, Chronic-Phase | 0.000271442 | 1 | 0 | BeFree |
| Long QT Syndrome | 0.000271442 | 1 | 1 | BeFree |
| Lymphedema | 0.000271442 | 1 | 0 | BeFree |
| Lymphocytosis | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, Undifferentiated | 0.000271442 | 1 | 0 | BeFree |
| Lymphoproliferative Disorders | 0.000271442 | 1 | 0 | BeFree |
| Multiple Personality Disorder | 0.000271442 | 1 | 0 | BeFree |
| Myelodysplasia | 0.000271442 | 1 | 0 | BeFree |
| Myeloproliferative disease | 0.000271442 | 1 | 0 | BeFree |
| Neoplasms, Radiation-Induced | 0.000271442 | 1 | 0 | BeFree |
| Nervous System Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Nevus | 0.000271442 | 1 | 0 | BeFree |
| Parathyroid Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Pituitary Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Sezary Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Teratoma | 0.000271442 | 1 | 0 | BeFree |
| Xeroderma Pigmentosum | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, T-Cell, Cutaneous | 0.000271442 | 1 | 0 | BeFree |
| Pleural Effusion, Malignant | 0.000271442 | 1 | 0 | BeFree |
| Polyendocrinopathies, Autoimmune | 0.000271442 | 1 | 0 | BeFree |
| Plasmacytosis | 0.000271442 | 1 | 0 | BeFree |
| Chronic gastritis | 0.000271442 | 1 | 0 | BeFree |
| Monocytosis | 0.000271442 | 1 | 0 | BeFree |
| Adenosis of Breast | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
| Myocardial Ischemia | 0.000271442 | 1 | 0 | BeFree |
| Cutaneous Melanoma | 0.000271442 | 1 | 0 | BeFree |
| Complete trisomy 18 syndrome | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of mouth | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of gallbladder | 0.000271442 | 1 | 0 | BeFree |
| Subependymal Giant Cell Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
| Liposarcoma, Pleomorphic | 0.000271442 | 1 | 0 | BeFree |
| Germ cell tumor | 0.000271442 | 1 | 0 | BeFree |
| Neuroectodermal Tumor, Melanotic | 0.000271442 | 1 | 0 | BeFree |
| Lichen Planus, Oral | 0.000271442 | 1 | 0 | BeFree |
| Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
| Giant Cell Tumor of Bone | 0.000271442 | 1 | 0 | BeFree |
| Alveolar rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Epithelioid hemangioendothelioma | 0.000271442 | 1 | 0 | BeFree |
| Lip and Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Comedone | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of female breast | 0.000271442 | 1 | 0 | BeFree |
| Gallbladder Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of penis | 0.000271442 | 1 | 0 | BeFree |
| Medullary carcinoma of thyroid | 0.000271442 | 1 | 0 | BeFree |
| Papillary thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Neoplasm, Residual | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of male breast | 0.000271442 | 1 | 0 | BeFree |
| Multiple tumors | 0.000271442 | 1 | 0 | BeFree |
| Spastic syndrome | 0.000271442 | 1 | 0 | BeFree |
| Cornelia De Lange Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Severe hereditary factor VIII deficiency disease | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma breast stage IV | 0.000271442 | 1 | 0 | BeFree |
| Stage III Prostate Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| metastatic pheochromocytoma | 0.000271442 | 1 | 0 | BeFree |
| stage, non-small cell lung cancer | 0.000271442 | 1 | 0 | BeFree |
| Primary central nervous system lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Malignant lymphoma centroblastic, diffuse | 0.000271442 | 1 | 0 | BeFree |
| Restenosis | 0.000271442 | 1 | 0 | BeFree |
| High-Grade Squamous Intraepithelial Lesions | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma, metastatic | 0.000271442 | 1 | 0 | BeFree |
| Carcinoid tumor no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
| Serous cystadenoma, borderline malignancy | 0.000271442 | 1 | 0 | BeFree |
| Inflammatory carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Epithelioid hemangioendothelioma, malignant | 0.000271442 | 1 | 0 | BeFree |
| Thyroid associated opthalmopathies | 0.000271442 | 1 | 0 | BeFree |
| Breast Cancer, Familial | 0.000271442 | 1 | 1 | BeFree |
| Intestinal Cancer | 0.000271442 | 1 | 0 | BeFree |
| Hemimegalencephaly | 0.000271442 | 1 | 0 | BeFree |
| Trisomy 11 | 0.000271442 | 1 | 0 | BeFree |
| Low grade B-cell lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Plasma cell tumor, malignant | 0.000271442 | 1 | 0 | BeFree |
| Ewings sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Toxic Shock Syndrome | 0.000271442 | 1 | 0 | BeFree |
| vascular disease occlusive | 0.000271442 | 1 | 0 | BeFree |
| Primary malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
| Multiple Sclerosis, Relapsing-Remitting | 0.000271442 | 1 | 0 | BeFree |
| Malignant Pleural Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
| Oestrogen deficiency | 0.000271442 | 1 | 0 | BeFree |
| Precursor B-lymphoblastic lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Leukemia secondary | 0.000271442 | 1 | 0 | BeFree |
| Philadelphia chromosome positive | 0.000271442 | 1 | 0 | BeFree |
| Growth failure | 0.000271442 | 1 | 0 | BeFree |
| Chromosome 17 trisomy | 0.000271442 | 1 | 0 | BeFree |
| Plasma cell dyscrasia | 0.000271442 | 1 | 0 | BeFree |
| Progonoma | 0.000271442 | 1 | 0 | BeFree |
| Atypical teratoid/rhabdoid tumor | 0.000271442 | 1 | 0 | BeFree |
| Chronic leukemia (category) | 0.000271442 | 1 | 0 | BeFree |
| Precursor B-cell lymphoblastic lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Chronic myeloproliferative disorder | 0.000271442 | 1 | 0 | BeFree |
| Partial Trisomy | 0.000271442 | 1 | 0 | BeFree |
| Post-transplant lymphoproliferative disorder, polymorphic | 0.000271442 | 1 | 0 | BeFree |
| Adenoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
| Low Grade Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
| Papillary Renal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Skin atheroma | 0.000271442 | 1 | 0 | BeFree |
| Liver regeneration disorder | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
| AIDS-Related Plasmablastic Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Adult Diffuse Large B-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Classical Hodgkin's Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Primary Cutaneous Follicle Center Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Hereditary Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Malignant Mixed Mesodermal (Mullerian) Tumor | 0.000271442 | 1 | 0 | BeFree |
| Mature B-Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Mature B-Cell Non-Hodgkin Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Sporadic Burkitt's lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Well Differentiated Pancreatic Endocrine Tumor | 0.000271442 | 1 | 0 | BeFree |
| Benign melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
| Desmoplastic | 0.000271442 | 1 | 0 | BeFree |
| Poorly Differentiated Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| Smoldering myeloma | 0.000271442 | 1 | 0 | BeFree |
| Glioblastoma Multiforme | 0.000271442 | 1 | 0 | BeFree |
| Atypical Burkitt's lymphoma | 0.000271442 | 1 | 0 | BeFree |
| NUT Midline Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Uterine Corpus Cancer | 0.000271442 | 1 | 0 | BeFree |
| Plasma Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 0.000271442 | 1 | 0 | BeFree |
| B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Plasmablastic Lymphoma of the Oral Mucosa | 0.000271442 | 1 | 0 | BeFree |
| Familial renal cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Ocular Adnexal Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Anaplastic Medulloblastoma | 0.000271442 | 1 | 0 | BeFree |
| Early-Stage Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Micropapillary carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 0.000271442 | 1 | 0 | BeFree |
| Melanocytic nevus of skin | 0.000271442 | 1 | 0 | BeFree |
| Lymphomas in children | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。